Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Literature DB >> 20555111

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S Aebi¹, T Davidson, G Gruber, M Castiglione.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2010 PMID： 20555111 DOI： 10.1093/annonc/mdq159

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

30 in total

1. Bone targeted therapies in early breast cancer.

Authors: Keo Tabane; Daniel A Vorobiof
Journal: Curr Treat Options Oncol Date: 2011-12

2. Breast Cancer Biomarkers: Utility in Clinical Practice.

Authors: Fanny Le Du; Naoto T Ueno; Ana M Gonzalez-Angulo
Journal: Curr Breast Cancer Rep Date: 2013-12

Review 3. Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer: Recommendations from an evidence-based provincial guideline.

Authors: Melissa Shea-Budgell; May Lynn Quan; Blair Mehling; Claire Temple-Oberle
Journal: Plast Surg (Oakv) Date: 2014 Impact factor: 0.947

4. Comparing Health-Related Quality of Life among Breast Cancer Patients Receiving Different Plans of Treatment, Egypt.

Authors: Eman M Mortada; Reham A Salem; Omnia S Elseifi; Osama M Khalil
Journal: J Community Health Date: 2018-12

5. A retrospective study on screening and management of osteoporosis in breast cancer women treated with aromatase inhibitors in Libya.

Authors: Hanan Saaddedin Abushwereb; M Elhabash; S Elhamshari; H Eshaefi
Journal: Clin Cases Miner Bone Metab Date: 2017-02-10

6. HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity.

Authors: Domas Vaitiekus; Gintare Muckiene; Audrone Vaitiekiene; Liveta Sereikaite; Ruta Inciuraite; Ruta Insodaite; Daiva Cepuliene; Juozas Kupcinskas; Rasa Ugenskiene; Renaldas Jurkevicius; Elona Juozaityte
Journal: Cardiovasc Toxicol Date: 2020-08-03 Impact factor: 3.231

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1. Bone targeted therapies in early breast cancer.

2. Breast Cancer Biomarkers: Utility in Clinical Practice.

Review 3. Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer: Recommendations from an evidence-based provincial guideline.

4. Comparing Health-Related Quality of Life among Breast Cancer Patients Receiving Different Plans of Treatment, Egypt.

5. A retrospective study on screening and management of osteoporosis in breast cancer women treated with aromatase inhibitors in Libya.

6. HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity.

7. Patient surveillance after initial breast cancer therapy: variation by physician specialty.

8. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.

9. Osteoporosis and aromatase inhibitors: experience and future prospects.

10. Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial.